Skip to content
DataLookout
Menu

NCT07930260

Efficacy and Safety of Kabalin Cap.(Pregabalin) in Patients With Neuropathic Pain

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Proportion of participants with a ≥50% improvement in pain severity from baseline at Week 12
Timeframe: At Week 12 after enrollment

Sites

1 site in 1 country

  • HK inno.NSeoul, South Korea